| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Senior VP - CCO
1 company
Powell Lynne is a Senior VP - CCO at BIOCRYST PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $20K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2019 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CCO | Sale+OE | 12,000 | $9.75 | $116,940.00 | -100% | |
| Jan 18, 2019 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CCO | Sale+OE | 2,000 | $9.40 | $18,800.00 | -100% | |
| Jan 16, 2019 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CCO | Sale+OE | 3,046 | $9.27 | $28,236.42 | -100% | |
| Jan 14, 2019 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CCO | Sale+OE | 954 | $9.20 | $8,776.80 | -100% | |
| Dec 10, 2018 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CCO | Sale+OE | 4,000 | $9.06 | $36,240.00 | -100% | |
| Nov 21, 2018 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CCO | Sale+OE | 14,455 | $9.05 | $130,839.55 | -85.5% | |
| Nov 20, 2018 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CCO | Sale+OE | 15,470 | $8.55 | $132,315.44 | -44.0% | |
| Nov 8, 2018 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CCO | Sale+OE | 5,580 | $8.14 | $45,432.00 | -24.5% | |
| Nov 5, 2018 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CCO | Sale+OE | 100 | $8.00 | $800.00 | -1.1% | |
| Nov 2, 2018 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CCO | Sale+OE | 1,000 | $8.00 | $8,000.00 | -10.4% |